Bacterial synthesis, purification, and solubilization of transmembrane segments of ErbB family receptors

Molecular Biology

Volumn 45, Issue 5, 2011, Pages 823-832

  Goncharuk, M V ^a,b   Schulga, A A ^a   Ermolyuk, Ya S ^a   Tkach, E N ^a   Goncharuk, S A ^a,b   Pustovalova, Yu E ^a   Mineev, K S ^a   Bocharov, E V ^a   Maslennikov, I V ^a   Arseniev, A S ^a   Kirpichnikov, M P ^a,b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

bacterial expression; detergent solubilization; ErbB; membrane protein; NMR; purification

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 80053646132     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893311040066     Document Type: Article

References (55)

1. Olayioye M. A., Neve R. M., Lane H. A., Hynes N. E. 2000. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167.
2. Yarden Y., Sliwkowski M. X. 2001. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127-137.
3. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell. 103, 211-225.
4. Yarden Y., Ullrich A. 1988. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57, 443-478.
5. Fantl W. J., Johnson D. E., Williams L. T. 1993. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62, 453-481.
6. Rajkumar T., Gullick W. J. 1994. The type I growth factor receptors in human breast cancer. Breast Cancer Res. Treat. 29, 3-9.
7. Warren C. M., Landgraf R. 2006. Signaling through ERBB receptors: Multiple layers of diversity and control. Cell. Signal. 18, 923-933.
8. Moriki T., Maruyama H., Maruyama I. N. 2001. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311, 1011-1026.
9. Holbro T., Civenni G., Hynes N. E. 2003. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284, 99-110.
10. Woodburn J. R. 1999. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther. 82, 241-250.
11. Muraoka-Cook R. S., Feng S. M., Strunk K. E., Earp H. S. III. 2008. ErbB4/HER4: Role in mammary gland development, differentiation and growth inhibition. J. Mammary Gland Biol. Neoplasia. 13, 235-246.
12. Barnes N. L., Khavari S., Boland G. P., Cramer A., Knox W. F., Bundred N. J. 2005. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin. Cancer Res. 11, 2163-2168.
13. Naresh A., Long W., Vidal G. A., Wimley W. C., Marrero L., Sartor C. I., Tovey S., Cooke T. G., Bartlett J. M., Jones F. E. 2006. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res. 66, 6412-6420.
14. Schlessinger J. 2002. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 110, 669-672.
15. Tao R. H., Maruyama I. N. 2008. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J. Cell Sci. 121, 3207-3217.
16. Bennasroune A., Fickova M., Gardin A., Dirrig-Grosch S., Aunis D., Cremel G., Hubert P. 2004. Transmembrane peptides as inhibitors of ErbB receptor signaling. Mol. Biol. Cell. 15, 3464-3474.
17. Duneau J. P., Vegh A. P., Sturgis J. N. 2007. A dimerization hierarchy in the transmembrane domains of the HER receptor family. Biochemistry. 46, 2010-2019.
18. Mendrola J. M., Berger M. B., King M. C., Lemmon M. A. 2002. The single transmembrane domains of ErbB receptors self-associate in cell membranes. J. Biol. Chem. 277, 4704-4712.
19. Li E., Hristova K. 2006. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry. 45, 6241-6251.
20. Partridge A. W., Therien A. G., Deber C. M. 2002. Polar mutations in membrane proteins as a biophysical basis for disease. Biopolymers. 66, 350-358.
21. Frank B., Hemminki K., Wirtenberger M., Bermejo J. L., Bugert P., Klaes R., Schmutzler R. K., Wappenschmidt B., Bartram C. R., Burwinkel B. 2005. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. Carcinogenesis. 26, 643-647.
22. Escher C., Cymer F., Schneider D. 2009. Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains. J. Mol. Biol. 389, 10-16.
23. Mackenzie K. R. 2006. Folding and stability of alphahelical integral membrane proteins. Chem. Rev. 106, 1931-1977.
24. Russ W. P., Engelman D. M. 2000. The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 296, 911-919.
25. Curran A. R., Engelman D. M. 2003. Sequence motifs, polar interactions and conformational changes in helical membrane proteins. Curr. Opin. Struct. Biol. 13, 412-417.
26. Enosh A., Fleishman S. J., Ben-Tal N., Halperin D. 2007. Prediction and simulation of motion in pairs of transmembrane alpha-helices. Bioinformatics. 23, 212-218.
27. Smith S. O., Smith C., Shekar S., Peersen O., Ziliox M., Aimoto S. 2002. Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. Biochemistry. 41, 9321-9332.
28. Fleishman S. J., Schlessinger J., Ben-Tal N. 2002. A putative molecular-activation switch in the transmembrane domain of erbB2. Proc. Natl. Acad. Sci. U. S. A. 99, 15937-15940.
29. Jiang G., Hunter T. 1999. Receptor signaling: When dimerization is not enough. Curr. Biol. 9, 568-571.
30. Carpenter E. P., Beis K., Cameron A. D., Iwata S. 2008. Overcoming the challenges of membrane protein crystallography. Curr. Opin. Struct. Biol. 18, 581-586.
31. Junge F., Schneider B., Reckel S., Schwarz D., Dotsch V., Bernhard F. 2008. Large-scale production of functional membrane proteins. Cell. Mol. Life Sci. 65, 1729-1755.
32. Midgett C. R., Madden D. R. 2007. Breaking the bottleneck: Eukaryotic membrane protein expression for high-resolution structural studies. J. Struct. Biol. 160, 265-274.
33. MacKenzie K. R., Prestegard J. H., Engelman D. M. 1997. A transmembrane helix dimer: Structure and implications. Science. 276, 131-133.
34. Bocharov E. V., Pustovalova Y. E., Pavlov K. V., Volynsky P. E., Goncharuk M. V., Ermolyuk Y. S., Karpunin D. V., Schulga A. A., Kirpichnikov M. P., Efremov R. G., Maslennikov I. V., Arseniev A. S. 2007. Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J. Biol. Chem. 282, 16256-16266.
35. Sulistijo E. S., Mackenzie K. R. 2009. Structural basis for dimerization of the BNIP3 transmembrane domain. Biochemistry. 48, 5106-5120.
36. Bocharov E. V., Mineev K. S., Volynsky P. E., Ermolyuk Y. S., Tkach E. N., Sobol A. G., Chupin V. V., Kirpichnikov M. P., Efremov R. G., Arseniev A. S. 2008. Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state. J. Biol. Chem. 283, 6950-6956.
37. Mineev K. S., Bocharov E. V., Pustovalova Y. E., Bocharova O. V., Chupin V. V., Arseniev A. S. 2010. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. J. Mol. Biol. 400, 231-243.
38. Bocharov E. V., Mayzel M. L., Volynsky P. E., Goncharuk M. V., Ermolyuk Y. S., Schulga A. A., Artemenko E. O., Efremov R. G., Arseniev A. S. 2008. Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J. Biol. Chem. 283, 29385-29395.
39. Bocharov E. V., Mayzel M. L., Volynsky P. E., Mineev K. S., Tkach E. N., Ermolyuk Y. S., Schulga A. A., Efremov R. G., Arseniev A. S. 2010. Left-handed dimer of EphA2 transmembrane domain: Helix packing diversity among receptor tyrosine kinases. Biophys. J. 98, 881-889.
40. Gullick W. J., Bottomley A. C., Lofts F. J., Doak D. G., Mulvey D., Newman R., Crumpton M. J., Sternberg M. J., Campbell I. D. 1992. Three dimensional structure of the transmembrane region of the proto-oncogenic and oncogenic forms of the neu protein. EMBO J. 11, 43-48.
41. Rigby A. C., Barber K. R., Shaw G. S., Grant C. W. 1996. Transmembrane region of the epidermal growth factor receptor: Behavior and interactions via 2H NMR. Biochemistry. 35, 12591-12601.
42. Jones D. H., Barber K. R., Grant C. W. 1998. Sequence-related behaviour of transmembrane domains from class I receptor tyrosine kinases. Biochim. Biophys. Acta. 1371, 199-212.
43. Houliston R. S., Hodges R. S., Sharom F. J., Davis J. H. 2003. Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE. FEBS Lett. 535, 39-43.
44. Khemtémourian L., Lavielle S., Bathany K., Schmitter J. M., Dufourc E. J. 2006. Revisited and large-scale synthesis and purification of the mutated and wild type neu/erbB-2 membrane-spanning segment. J. Pept. Sci. 12, 361-368.
45. Jones D. H., Ball E. H., Sharpe S., Barber K. R., Grant C. W. 2000. Expression and membrane assembly of a transmembrane region from Neu. Biochemistry. 39, 1870-1878.
46. Sharpe S., Barber K. R., Grant C. W. 2000. Val(659) → Glu mutation within the transmembrane domain of ErbB-2: Effects measured by (2)H NMR in fluid phospholipid bilayers. Biochemistry. 39, 6572-6580.
47. Volynsky P. E., Bocharov E. V., Nolde D. E., Vereschaga Ya. A., Mayzel M. L., Mineev K. S., Mineeva E. A., Pustovalova Yu. E., Gagnidze I. E., Efremov R. G., Arseniev A. S. 2006. Solution of the spatial structure of dimeric transmembrane domains of proteins by heteronuclear NMR spectroscopy and molecular modeling. Biophysics. 51, 23-27.
48. Kirpichnikov M. P., Goncharuk M. V., Ermolyuk Ya. S., Goncharuk S. A., Shul'ga A. A. Maslennikov I. V., Arseniev A. S. 2005. Structural biology of membrane peptides. Tekhnol. Zhivykh Sistem. 2, 20-27.
49. Gasparian M. E., Ostapchenko V. G., Schulga A. A., Dolgikh D. A., Kirpichnikov M. P. 2003. Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli. Protein Expr. Purif. 31, 133-139.
50. Sreerama N., Woody R. W. 2000. Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 287, 252-260.
51. Melchers K., Weitzenegger T., Buhmann A., Steinhilber W., Sachs G., Schäfer K. P. 1996. Cloning and membrane topology of a P type ATPase from Helicobacter pylori. J. Biol. Chem. 271, 446-457.
52. Kim H. J., Howell S. C., van Horn W. D., Jeon Y. H., Sanders C. R. 2009. Recent advances in the application of solution NMR spectroscopy to multi-span integral membrane proteins. Prog. Nucl. Magn. Reson. Spectrosc. 55, 335-360.
53. Luchette P. A., Vetman T. N., Prosser R. S., Hancock R. E., Nieh M. P., Glinka C. J., Krueger S., Katsaras J. 2001. Morphology of fast-tumbling bicelles: A small angle neutron scattering and NMR study. Biochim. Biophys. Acta. 1513, 83-94.
54. Andersson A., Mäler L. 2005. Magnetic resonance investigations of lipid motion in isotropic bicelles. Langmuir. 21, 7702-7709.
55. Jura N., Endres N. F., Engel K., Deindl S., Das R., Lamers M. H., Wemmer D. E., Zhang X., Kuriyan J. 2009. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell. 137, 1293-1307.